Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Recurrence 5Lymphoma, Large B-Cell, Diffuse 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 2Lymphoma, B-Cell 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Plasmacytoma 1Nasopharyngeal Carcinoma 1Meningeal Carcinomatosis 1Lymphoma 1Liver Neoplasms 1Glioma 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 23fludarabine 14Rituximab 14Specimen Handling 9Magnetic Resonance Spectroscopy 8Doxorubicin 7pirtobrutinib 6Vincristine 6Prednisone 6polatuzumab vedotin 5obinutuzumab 5Biopsy 5zanubrutinib 4glofitamab 4Nivolumab 4Etoposide 4Dexamethasone 4tazemetostat 3tafasitamab 3pembrolizumab 3ibrutinib 3fludarabine phosphate 3acalabrutinib 3Leukapheresis 3Bendamustine Hydrochloride 3venetoclax 2pomalidomide 2loncastuximab tesirine 2etoposide phosphate 2cemiplimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, B-Cell × Immunotherapy, Adoptive × 90 days × Clear all
NCT05312476 2026-06-03

Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

The First Affiliated Hospital of Soochow University

Phase 2 Withdrawn
Lymphoid

Lymphoma, B-Cell

NCT07584889 2026-05-13

CAR-p40-T

Shenzhen University General Hospital

Phase 1/2 Recruiting
10 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡